The Top Two Vaccine Stocks to Avoid, Near-Term


There’s no such thing as a perfect trial.

Fortunately, there are safeguards in place to stop trials in the event of a mishap.  We’ve seen two just this week, which could put a good deal of pressure on their stocks.

Hopefully, the events won’t prevent these companies from moving forward for long.

Shares of Eli Lilly (LLY) are under pressure.   “Safety is of the utmost importance to Lilly," an Eli Lilly spokesperson told Fox Business. "We are aware that, out of an abundance of caution, th...

Register Now

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Already a member? Login below, or click here to register now for free.